NVDA
NVIDIA
-- 144.470 TSLA
Tesla
-- 410.440 PLTR
Palantir
-- 79.890 CRNC
Cerence
-- 19.330 MSTR
MicroStrategy
-- 339.660 
Henan Taloph's lower P/S ratio may be justified due to slowe...
Henan Taloph's lower P/S ratio may be justified due to slower growth rates than industry rivals. Doubts about the company's ability to maintain robust growth in line with industry may hinder share price recovery.
Little Excitement Around Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment